Literature DB >> 22273700

[The current pathogen spectrum--what are we fighting against?].

S Scheithauer1, H Häfner, S W Lemmen.   

Abstract

Surgical site infections are mainly caused by bacteria from the patients' skin or gut flora representing endogenous infections. In orthopedic and trauma surgery the skin commensals dominate and as a consequence Gram-positive bacteria are the main pathogens, particularly S. aureus. Additionally and especially in the case of foreign body infections, less virulent pathogens, e.g. coagulase-negative staphylococci play an important role. Due to newer microbiological techniques in detecting pathogens the spectrum of causative organisms is steadily increasing. As known for other nosocomial infections the relevance of multidrug resistant bacteria in surgical site infections is growing and the key player is methicillin-resistant S. aureus (MRSA); however vancomycin-resistant enterococci (VRE), extended spectrum betalactamases and/or carbapenemases producing enterobacteria and recently even panresistant Acinetobacter baumannii isolates have to be considered.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22273700     DOI: 10.1007/s00132-011-1834-2

Source DB:  PubMed          Journal:  Orthopade        ISSN: 0085-4530            Impact factor:   1.087


  18 in total

1.  An operating surveillance system of surgical-site infections in The Netherlands: results of the PREZIES national surveillance network. Preventie van Ziekenhuisinfecties door Surveillance.

Authors:  E L Geubbels; A J Mintjes-de Groot; J M van den Berg; A S de Boer
Journal:  Infect Control Hosp Epidemiol       Date:  2000-05       Impact factor: 3.254

2.  Is the burden of Staphylococcus aureus among patients with surgical-site infections growing?

Authors:  John A Jernigan
Journal:  Infect Control Hosp Epidemiol       Date:  2004-06       Impact factor: 3.254

3.  Staphylococcus aureus small colony variants in prosthetic joint infection.

Authors:  Parham Sendi; Markus Rohrbach; Peter Graber; Reno Frei; Peter E Ochsner; Werner Zimmerli
Journal:  Clin Infect Dis       Date:  2006-09-08       Impact factor: 9.079

Review 4.  Diagnosis and management of prosthetic joint infection.

Authors:  Philippa C Matthews; Anthony R Berendt; Martin A McNally; Ivor Byren
Journal:  BMJ       Date:  2009-05-29

5.  Mycobacterium xenopi spinal infections after discovertebral surgery: investigation and screening of a large outbreak.

Authors:  P Astagneau; N Desplaces; V Vincent; V Chicheportiche; A Botherel; S Maugat; K Lebascle; P Léonard; J Desenclos; J Grosset; J Ziza; G Brücker
Journal:  Lancet       Date:  2001-09-01       Impact factor: 79.321

Review 6.  An overview of nosocomial infections, including the role of the microbiology laboratory.

Authors:  T G Emori; R P Gaynes
Journal:  Clin Microbiol Rev       Date:  1993-10       Impact factor: 26.132

7.  Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection.

Authors:  John J Engemann; Yehuda Carmeli; Sara E Cosgrove; Vance G Fowler; Melissa Z Bronstein; Sharon L Trivette; Jane P Briggs; Daniel J Sexton; Keith S Kaye
Journal:  Clin Infect Dis       Date:  2003-02-07       Impact factor: 9.079

Review 8.  Surgical site infections: epidemiology, microbiology and prevention.

Authors:  C D Owens; K Stoessel
Journal:  J Hosp Infect       Date:  2008-11       Impact factor: 3.926

9.  Health and economic impact of surgical site infections diagnosed after hospital discharge.

Authors:  Eli N Perencevich; Kenneth E Sands; Sara E Cosgrove; Edward Guadagnoli; Ellen Meara; Richard Platt
Journal:  Emerg Infect Dis       Date:  2003-02       Impact factor: 6.883

10.  Clinical consequences and cost of limiting use of vancomycin for perioperative prophylaxis: example of coronary artery bypass surgery.

Authors:  G Zanetti; S J Goldie; R Platt
Journal:  Emerg Infect Dis       Date:  2001 Sep-Oct       Impact factor: 6.883

View more
  2 in total

1.  [Infections of hip and knee endoprostheses. Spectrum of pathogens and the role of multiresistant bacteria].

Authors:  D Zajonz; L Wuthe; A C Rodloff; T Prietzel; G Freiherr von Salis-Soglio; A Roth; C-E Heyde; C Josten; M Ghanem
Journal:  Chirurg       Date:  2016-04       Impact factor: 0.955

2.  Outcome of total knee replacement following explantation and cemented spacer therapy.

Authors:  Mohamed Ghanem; Dirk Zajonz; Juliane Bollmann; Vanessa Geissler; Torsten Prietzel; Michael Moche; Andreas Roth; Christoph-E Heyde; Christoph Josten
Journal:  GMS Interdiscip Plast Reconstr Surg DGPW       Date:  2016-03-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.